Revolution Medicines’ Acquisition of EQRx

Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx.Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement through…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now